Kurt İnci, B. Et Al. 2024. The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma. Journal of oncological sciences , vol.10, no.1 , 32-38.

Kurt İnci, B., Gürler, F., Sütcüoğlu, O., Ünsal, O., Aslan, V., Yazıcı, O., ... Üner, A.(2024). The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma. Journal of oncological sciences , vol.10, no.1, 32-38.

Kurt İnci, Bediz Et Al. "The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma," Journal of oncological sciences , vol.10, no.1, 32-38, 2024

Kurt İnci, Bediz K. Et Al. "The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma." Journal of oncological sciences , vol.10, no.1, pp.32-38, 2024

Kurt İnci, B. Et Al. (2024) . "The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma." Journal of oncological sciences , vol.10, no.1, pp.32-38.

@article{article, author={Bediz Kurt İnci Et Al. }, title={The Reallife Comparison of FOLFIRINOX vs Gemcitabine Platinum Combination as a First-Line Treatment in Patients with Pancreatic Carcinoma}, journal={Journal of oncological sciences}, year=2024, pages={32-38} }